Glipizide

Cat. No.: 0225LY-0790

Appearance: Solid

Purity: ≥99%

Identity: Confirmed by NMR, and HPLC.

Size:

INQUIRY Datasheet MSDS

Add to basket

Product Overview

Description: Glipizide is a second-generation, short-acting sulfonylurea utilized for its hypoglycemic activity.

Synonym: 29094-61-9; Glydiazinamide; Glibenese; Melizide; Aldiab; Ozidia; N-(4-(N-(cyclohexylcarbamoyl)sulfamoyl)phenethyl)-5-methylpyrazine-2-carboxamide; Pyrazinecarboxamide, N-(2-(4-((((cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-5-methyl-; N-(4-(beta-(5-Methylpyrazine-2-carboxamido)ethyl)benzenesulphonyl)-N'-cyclohexylurea; Urea, 1-cyclohexyl-3-((p-(2-(5-methylpyrazinecarboxamido)ethyl)phenyl)sulfonyl)-; N-(2-{4-[(cyclohexylcarbamoyl)sulfamoyl]phenyl}ethyl)-5-methylpyrazine-2-carboxamide

CAS No.: 29094-61-9

Compound CID: 3478

Formula: C₂₁H₂₇N₅O₄S

Formula Weight: 445.54

Specification

Targets&IC50: KATP: 6.4 nM ATP-sensitive potassium (IC50)

Relative Density: 1.34 g/cm³

Stability: 3 years in powder form.

Storage: Storage at -20°C.

Applications: Glipizide can be used in diabetes research to study the stimulation of insulin secretion through the closure of ATP-sensitive potassium channels.